"St. Clair Hospital Cancer Center Radiation Oncology, affiliated with UPMC Hillman Cancer Center (Radiation Oncology) is a Cancer Treatment Center located in Pittsburgh.Visit our website to learn more about the conditions we treat and the services we offer. Schedule your appointment today. UPMC is committed to protecting our communities from the spread of COVID-19. We continue to require people who come to any UPMC facility to wear a facemask that covers their nose and mouth and to practice other preventative efforts like social distancing, even if fully vaccinated."

During the past decade, UPMC-Saint Clair Hospital Cancer Center conducted 65 clinical trials. In the 10-year time frame, 65 clinical trials started and 32 clinical trials were completed, i.e. on average, 49.2% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 29 clinical trials were completed. i.e. 126.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UPMC-Saint Clair Hospital Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 37 trials, followed by "SWOG Cancer Research Network" with 16 trials sponsored, "Alliance for Clinical Trials in Oncology" with 15 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored and "NRG Oncology" with 7 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC-Saint Clair Hospital Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 49 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator and "Astellas Pharma US, Inc." with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "UPMC-Saint Clair Hospital Cancer Center" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Recurrent Lung Non-Small Cell Carcinoma" (6 trials), "Stage IIIA Breast Cancer" (6 trials) and "Invasive Breast Carcinoma" (5 trials). Many other conditions were trialed in "UPMC-Saint Clair Hospital Cancer Center" in a lesser frequency.

Most popular intervention types in "UPMC-Saint Clair Hospital Cancer Center" are "Drug" (73 trials), "Other" (56 trials), "Biological" (33 trials), "Procedure" (25 trials) and "Radiation" (25 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (32 trials), "Quality-of-Life Assessment" (20 trials), "Cisplatin" (14 trials), "Computed Tomography" (14 trials) and "Carboplatin" (13 trials). Other intervention names were less common.

The vast majority of trials in "UPMC-Saint Clair Hospital Cancer Center" are 70 trials for "All" genders, 13 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "UPMC-Saint Clair Hospital Cancer Center". undefined are not yet recruiting, 27 are recruiting, 39 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in UPMC-Saint Clair Hospital Cancer Center, 3 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in UPMC-Saint Clair Hospital Cancer Center, 0 "Phase 1" clinical trials were conducted, 46 "Phase 2" clinical trials and 53 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".